The Gilenya Pregnancy Registry

CompletedOBSERVATIONAL
Enrollment

312

Participants

Timeline

Start Date

October 15, 2011

Primary Completion Date

May 29, 2024

Study Completion Date

May 29, 2024

Conditions
Multiple Sclerosis
Interventions
DRUG

Fingolimod

fingolimod 0.5 mg/day, including generic versions of fingolimod

Trial Locations (61)

189

Novartis Investigative Site, Roma

1011

Novartis Investigative Site, Lausanne

1204

Novartis Investigative Site, Budapest

1683

Novartis Investigative Site, Nicosia

2000

Novartis Investigative Site, Maribor

2930

Novartis Investigative Site, Brasschaat

3000

Novartis Investigative Site, Leuven

3010

Novartis Investigative Site, Bern

3128

Novartis Investigative Site, Box Hill

4020

Novartis Investigative Site, Linz

4031

Novartis Investigative Site, Basel

6400

Novartis Investigative Site, Sønderborg

8000

Novartis Investigative Site, Bahía Blanca

8036

Novartis Investigative Site, Graz

9000

Novartis Investigative Site, Aalborg

9007

Novartis Investigative Site, Sankt Gallen

10043

Novartis Investigative Site, Orbassano

11211

Novartis Investigative Site, Riyadh

16132

Novartis Investigative Site, Genova

20132

Novartis Investigative Site, Milan

20520

Novartis Investigative Site, Turku

21499

Novartis Investigative Site, Jeddah

28222

Novartis Investigative Site, Madrid

33308

Novartis Investigative Site, Fort Lauderdale

41071

Novartis Investigative Site, Seville

44791

Novartis Investigative Site, Bochum

50134

Novartis Investigative Site, Florence

50269

Novartis Investigative Site, Cahors

52621

Novartis Investigative Site, Ramat Gan

58201

Novartis Investigative Site, Grand Forks

69677

Novartis Investigative Site, Bron

95123

Novartis Investigative Site, Catania

127018

Novartis Investigative Site, Moscow

9112001

Novartis Investigative Site, Jerusalem

02139

Novartis Investigative Site, Cambridge

X5000FAL

Novartis Investigative Site, Córdoba

21941-913

Novartis Investigative Site, Rio de Janeiro

H4M-2P4

Novartis Investigative Site, Saint-Laurent

Unknown

Novartis Investigative Site, Bogotá

Novartis Investigative Site, Amsterdam

Novartis Investigative Site, Abu Dhabi

Novartis Investigative Site, Dubai

708 52

Novartis Investigative Site, Ostrava-Poruba

8000 C

Novartis Investigative Site, Aarhus

DK-2100

Novartis Investigative Site, Copenhagen

FIN-33521

Novartis Investigative Site, Tampere

115 25

Novartis Investigative Site, Athens

H-9023

Novartis Investigative Site, Győr

D04 T6F

Novartis Investigative Site, Dublin

1107 2020

Novartis Investigative Site, Beirut

05300

Novartis Investigative Site, Mexico City

20-089

Novartis Investigative Site, Lubin

02-957

Novartis Investigative Site, Warsaw

2720-276

Novartis Investigative Site, Amadora

4099-001

Novartis Investigative Site, Porto

050098

Novartis Investigative Site, Bucharest

811 07

Novartis Investigative Site, Bratislava

413 45

Novartis Investigative Site, Gothenburg

NE1 4LP

Novartis Investigative Site, Newcastle upon Tyne

NR1 3SR

Novartis Investigative Site, Norwich

NG7 2UH

Novartis Investigative Site, Nottingham

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY